EUVIMEDEUVIMED entdecken
Open Access

KLF5 inhibition potentiates anti-PD1 efficacy by enhancing CD8 + T-cell-dependent antitumor immunity

Qi Wu, Zhou Liu, Zhijie Gao, Yao Luo, Fubing Li, ChuanYu Yang, Tiantian Wang, Xiangyu Meng, Haijun Chen, Juanjuan Li, Yanjie Kong, Chao Dong und 2 weitere

Theranostics · 2023

DOI: 10.7150/thno.82182 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theranostics, 2023. Verfasst von Qi Wu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Animal Models and Human Disease Mechanisms of the Chinese Academy of Sciences and Yunnan Province, KIZ-CUHK Joint Laboratory of Bio…. Hauptthemen laut MEDLINE: Dinoprostone, Transcription Factors. Die Arbeit wurde bisher 36-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DinoprostoneTranscription FactorsMiceAnimalsCyclooxygenase 2ImmunotherapyCD8-Positive T-LymphocytesTumor MicroenvironmentCell Line, TumorKruppel-Like Transcription Factors

Stichwörter der Autor:innen

CD8+ T cellCOX2KLF5PD1 blockerbreast cancer

Substanzen

Cyclooxygenase 2DinoprostoneTranscription FactorsKlf5 protein, mouseKruppel-Like Transcription Factors

Autor:innen und Institutionen

  • Key Laboratory of Animal Models and Human Disease Mechanisms of the Chinese Academy of Sciences and Yunnan Province, KIZ-CUHK Joint Laboratory of Bioresources and Molecular Research in Common Diseases, Kunming Institute…
  • Tongji University Cancer Center, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
  • Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
  • Medical Faculty of Kunming University of Science and Technology, Kunming, China.
  • Academy of Biomedical Engineering, Kunming Medical University, Kunming 650500, China.
  • School of Life Science, University of Science & Technology of China, Hefei, 230027, Anhui, China.

Zitieren

APA

Wu, Q., Liu, Z., Gao, Z., Luo, Y., Li, F., Yang, C., Wang, T., Meng, X., Chen, H., Li, J., Kong, Y., Dong, C., Sun, S., & Chen, C. (2023). KLF5 inhibition potentiates anti-PD1 efficacy by enhancing CD8 + T-cell-dependent antitumor immunity. Theranostics. https://doi.org/10.7150/thno.82182

Vancouver

Wu Q, Liu Z, Gao Z, Luo Y, Li F, Yang C, et al. KLF5 inhibition potentiates anti-PD1 efficacy by enhancing CD8 + T-cell-dependent antitumor immunity. Theranostics. 2023. doi:10.7150/thno.82182

BibTeX
@article{Wu2023,
  author = {Wu, Qi and Liu, Zhou and Gao, Zhijie and Luo, Yao and Li, Fubing and Yang, ChuanYu and Wang, Tiantian and Meng, Xiangyu and Chen, Haijun and Li, Juanjuan and Kong, Yanjie and Dong, Chao and Sun, Si and Chen, Ceshi},
  title = {KLF5 inhibition potentiates anti-PD1 efficacy by enhancing CD8 + T-cell-dependent antitumor immunity},
  journal = {Theranostics},
  year = {2023},
  doi = {10.7150/thno.82182}
}
Kostenlos starten →